Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

2,608.00p
   
  • Change Today:
    -12.00p
  • 52 Week High: 2,992.00
  • 52 Week Low: 2,098.00
  • Currency: UK Pounds
  • Shares Issued: 65.05m
  • Volume: 492,097
  • Market Cap: £1,696.55m
  • RiskGrade: 174
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
5.27% above the market average5.27% above the market average5.27% above the market average5.27% above the market average5.27% above the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
1yr Revenue Growth
33.54% below the market average33.54% below the market average33.54% below the market average33.54% below the market average33.54% below the market average
21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
1yr DPS Growth
18.73% above the market average18.73% above the market average18.73% above the market average18.73% above the market average18.73% above the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
3.91% above the market average3.91% above the market average3.91% above the market average3.91% above the market average3.91% above the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average
Price Book Ratio
70.61% below the market average70.61% below the market average70.61% below the market average70.61% below the market average70.61% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
50.33% above the market average50.33% above the market average50.33% above the market average50.33% above the market average50.33% above the market average
40.98% above the sector average40.98% above the sector average40.98% above the sector average40.98% above the sector average40.98% above the sector average
Price Chg 3m
54.73% above the market average54.73% above the market average54.73% above the market average54.73% above the market average54.73% above the market average
21.31% above the sector average21.31% above the sector average21.31% above the sector average21.31% above the sector average21.31% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
33.19% above the market average33.19% above the market average33.19% above the market average33.19% above the market average33.19% above the market average
23.33% above the sector average23.33% above the sector average23.33% above the sector average23.33% above the sector average23.33% above the sector average
Momentum 20
98.84% below the market average98.84% below the market average98.84% below the market average98.84% below the market average98.84% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average
36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average
ROCE
66.46% below the market average66.46% below the market average66.46% below the market average66.46% below the market average66.46% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
84.15% above the market average84.15% above the market average84.15% above the market average84.15% above the market average84.15% above the market average
82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average
Forecast EPS
69.99% above the market average69.99% above the market average69.99% above the market average69.99% above the market average69.99% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
62.60% above the market average62.60% above the market average62.60% above the market average62.60% above the market average62.60% above the market average
75.61% above the sector average75.61% above the sector average75.61% above the sector average75.61% above the sector average75.61% above the sector average
Operating Profit Loss
22.21% above the market average22.21% above the market average22.21% above the market average22.21% above the market average22.21% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
59.55% above the market average59.55% above the market average59.55% above the market average59.55% above the market average59.55% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Cash
45.35% above the market average45.35% above the market average45.35% above the market average45.35% above the market average45.35% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
38.40% above the market average38.40% above the market average38.40% above the market average38.40% above the market average38.40% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Buys 1y
98.43% below the market average98.43% below the market average98.43% below the market average98.43% below the market average98.43% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
37.41% below the market average37.41% below the market average37.41% below the market average37.41% below the market average37.41% below the market average
37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average
Brokers Percent Neutral
5.91% above the market average5.91% above the market average5.91% above the market average5.91% above the market average5.91% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,608.00p
Change Today -12.00p
% Change -0.46 %
52 Week High 2,992.00
52 Week Low 2,098.00
Volume 492,097
Shares Issued 65.05m
Market Cap £1,696.55m
Beta 0.00
RiskGrade 174

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.62% below the market average95.62% below the market average95.62% below the market average95.62% below the market average95.62% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Price Trend
70.41% above the market average70.41% above the market average70.41% above the market average70.41% above the market average70.41% above the market average
57.38% above the sector average57.38% above the sector average57.38% above the sector average57.38% above the sector average57.38% above the sector average
Income
91.64% below the market average91.64% below the market average91.64% below the market average91.64% below the market average91.64% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Growth
71.18% below the market average71.18% below the market average71.18% below the market average71.18% below the market average71.18% below the market average
94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 07-Mar-19 15-Nov-18
Paid 04-Apr-19 30-Nov-18
Amount 8.90p 17.90p

Trades for 14-Jun-2019

Time Volume / Share Price
16:35 9,672 @ 2,608.00p
16:29 16 @ 2,608.00p
16:26 92 @ 2,610.00p
16:26 40 @ 2,610.00p
16:26 47 @ 2,610.00p

Genus Key Personnel

Chair Robert (Bob) Lawson
CEO Karim Bitar

Top of Page